NSN 6505-01-279-9627 · NIIN 012799627 · FSC 6505
NO DASHES 6505012799627
In Stock
IMIPENEM AND CILASTATIN FOR INJE
Drugs and Biologicals
Technical characteristics
8 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| AGXW | PHYSICAL FORM | POWDER |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | MILLIGRAMS CILASTATIN EQUIVALENT 500.000 AND MILLIGRAMS IMIPENEM EQUIVALENT 500.000 |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLIGRAMS OF ACTIVE INGREDIENT 1000.000 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | IMIPENEM & CILASTATIN SOD F/INJ SGL DOSE FI 1000MG 25S |
| FEAT | SPECIAL FEATURES | 15 ML CAPACITY GLASS VIAL SHALL HAVE A DOUBLE LEAD SCREW THREAD DESIGNED TO INTERLOCK WITH THE INLET PORT OF THE FOLLOWING DILUENT CONTAINERS: 6505-01-260-1237,6505-01-260-1238,6505-01-260-1239,6505-01-260-1241,6505-01-260-1242; THE ASSEMBLY OF THE DRUG VIAL AND DILUENT CONTAINER SHALL PROVIDE A TAMPER-RESISTANT,STERILE,LEAK PROOF BARRIER; EACH DRUG VIAL SHALL BE ENCLOSED IN AN UPPER AND LOWER PLASTIC SHROUD; THE UPPER SHROUD SHALL BE A STERILITY BARRIER WITH A PULL RING TO ALLOW EASE OF OPENING; THE LOWER SHROUD SHALL PROVIDE AN INTEGRAL HANGER TO SUPPORT THE ASSEMBLY AND ADMINISTRATION SET; THE VIAL SHALL HAVE A VIEWING PORT TO ALLOW CONFIRMATION OF DRUG ADDITION AND DISSOLUTION |
| MDES | MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |